Micro Cap Healthcare
Stocks Ranked by
Market Capitalization
Micro Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 550 micro cap Healthcare stocks — companies in the Healthcare sector with a market cap under $250M — worth a combined $33.5B.
The largest by market cap are Aurora Cannabis (ACB) at $247M, Fate Therapeutics (FATE) at $247M and Abeona Therapeutics (ABEO) at $246M.
Among institutional investors, Glass House Brands (GLAS) drew the most net new fund positions in Q2 2026: 50 funds opened new positions, taking total fund holders up 50 (1,667%) quarter-over-quarter.
- Combined market cap: $33.5B across 550 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Aurora Cannabis (ACB), $247M market cap.
- Most net new fund positions in Q2 2026: Glass House Brands (GLAS), +50 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.